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Abstract The mammalian eminentia thalami (EmT) (or
thalamic eminence) is an embryonic forebrain structure of
unknown function. Here, we examined the molecular and
cellular properties of the mouse EmT. We first studied
mRNA expression of signalling molecules and found that
the EmT is a structure, rich in expression of secreted fac-
tors, with Wnts being the most abundantly detected. We
then examined whether EmT tissue could induce cell fate
changes when grafted ectopically. For this, we transplanted
EmT tissue from a tau-GFP mouse to the ventral telen-
cephalon of a wild type host, a telencephalic region where
Wnt signalling is not normally active but which we showed
in culture experiments is competent to respond to Wnts.
We observed that the EmT was able to induce in adjacent
ventral telencephalic cells ectopic expression of Lef1, a
transcriptional activator and a target gene of the Wnt/b-
catenin pathway. These Lef1-positive;GFP-negative cells
expressed the telencephalic marker Foxg1 but not Ascl1,
which is normally expressed by ventral telencephalic cells.
These results suggest that the EmT has the capacity to
activate Wnt/b-catenin signalling in the ventral telen-
cephalon and to suppress ventral telencephalic gene
expression. Altogether, our data support a role of the EmT
as a signalling centre in the developing mouse forebrain.
Keywords Mouse  Development  Eminentia thalami 
Signalling centre  Wnt/b-catenin signalling
Introduction
The specification and organization of the central nervous
system (CNS) start at the gastrula stage of embryonic
development. Following the induction of its primordium,
the neural plate, by the Spemann–Mangold organizer, the
CNS is coarsely patterned along its anteroposterior and
dorsoventral axes (reviewed by Kiecker and Lumsden
2012). Neural induction and neural patterning in verte-
brates are mediated through signalling molecules (secreted
proteins) that emanate from signalling centres (Grove et al.
1998; Houart et al. 1998; Martinez 2001; Martinez and
Alvarado-Mallart 1989; Shimamura and Rubenstein 1997).
Local signalling centres are transient structures that
usually lie at the boundaries of the tissues they pattern, and
secrete molecules that diffuse through adjacent tissue to
establish gradients that confer positional information on the
cells (Grove and Fukuchi-Shimogori 2003; Kiecker and
Lumsden 2005; Wolpert 1996, 2011). Also, in a manner
similar to the early organizer, these local signalling centres
possess the ability to induce ectopic cell fates in host tis-
sues when heterotopically transplanted (Liu and Joyner
2001; Martinez et al. 1991; Raible and Brand 2004; Shi-
mamura and Rubenstein 1997). The recent combination of
genetic and molecular methods with morphological
approaches led to the identification of three such local
signalling centres in the developing forebrain: the anterior
neural ridge (ANR), the cortical hem (hem) and the zona
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limitans intrathalamica (ZLI). The ANR is located in the
most rostral part of the neural plate and is a source of Fgf
molecules. Ablation of the neural ridge leads to loss of
anterior forebrain fates in both mouse and zebrafish
(Houart et al. 1998, 2002; Shimamura and Rubenstein
1997). The hem is located in the dorsomedial telen-
cephalon and is rich in expression of Wnt and Bmp
molecules (Grove et al. 1998; Lee et al. 2000). It is
essential for the specification and patterning of the hip-
pocampal primordium. Gli3-/- mutant mice (extratoes)
with no hem tissue do not develop a hippocampus (Theil
et al. 1999; Tole et al. 2000), while Lhx2-null mouse chi-
meras develop ectopic hems that induce the formation of
multiple hippocampal fields (Mangale et al., 2008; Subra-
manian and Tole 2009). The ZLI is found in the dien-
cephalic primordium separating the prethalamus from the
thalamus. It secretes Shh and is crucial for diencephalic
specification and growth (Kiecker and Lumsden 2004;
Martinez-Ferre and Martinez 2012; Vieira et al. 2005).
The eminentia thalami (EmT) is a forebrain structure that
forms, alongwith the prethalamus, in prosomere 3 (p3) of the
prosencephalon (Puelles and Rubenstein 2003). It is flanked
medially by the prethalamus and laterally by the choroid
plexus of the lateral ventricle. Its rostral part forms the
posterior limit of the interventricular foramen of Monroe,
and the caudal part becomes attached to the ventral telen-
cephalon (Abbott and Jacobowitz 1999; Trujillo et al. 2005).
The role of the EmT in mammals has not been fully deter-
mined. It is postulated that the EmT may be a source of a
subtype of Cajal-Retzius cells in the developing neocortex
(Meyer 2010; Tissir et al. 2009). Based on its location at the
interface between the diencephalon and telencephalon and
its transient nature, Abbott and Jacobowitz (1999) suggested
that itmay act as an organizing centre in forebrain patterning.
A recent report proposes that the EmT forms part of the
forebrain hem system and may play a role in forebrain pat-
terning and development (Roy et al. 2014).
In this study, we aimed to shed light into the putative role
of the EmT as a forebrain signalling centre. Using an
extensive battery of signalling molecules, we first examined
the expression ofmembers of theWnt, Fgf and Bmp families
in the EmT from E11.5 to E17.5, to determine their temporal
and spatial patterns of expression. Members of these devel-
opmental control gene families have been implicated in
patterning other parts of the CNS (Grove et al. 1998; Shi-
mamura and Rubenstein 1997; Liu and Joyner 2001; Mar-
tinez 2001; Martinez et al. 1991; Houart et al. 2002). The
EmT was found to express several members of these fami-
lies, with Wnts being the most broadly and intensely
expressed signalling molecules. Next, we examined whether
the EmT had the capacity to induce ectopically cell fate
changes in the ventral telencephalon when heterotopically
transplanted. We observed that the EmT, but not neocortical
tissue, was able to induce in ventral telencephalic cells
ectopic expression of Lef1, a target gene and transcriptional
activator of theWnt/b-catenin pathway. These Lef1-positive
cells expressed the telencephalic marker Foxg1, but were
negative for the ventral telencephalicmarker Ascl1. Our data
explore the molecular and cellular properties of the EmT and
support the notion that this structure may act as a signalling
centre in the mouse developing forebrain.
Materials and methods
Animals
Animal care was according to institutional guidelines. Mice
were mated, and the morning of the vaginal plug was
designated as embryonic day (E) 0.5. Time-mated pregnant
mice were culled by cervical dislocation or overdose of
Isoflurane (Merial, UK). Embryos used for gene expression
analyses were obtained from wild type female mice of CD1
background. The donor eminentia thalami tissue was from
tau-GFP transgenic mouse embryos (Pratt et al. 2000).
Embryos were dissected out of the uteri in ice-cold phos-
phate-buffered saline (PBS). For culture experiments,
embryos were dissected in ice-cold 1 9 Kreb’s buffer.
Organotypic slice culture
Organotypic slice cultures of the E13.5 embryonic mouse
forebrain were done as previously described (Magnani
et al. 2010). Brains were removed and placed into ice-cold
1 9 Kreb’s buffer with 10 mM HEPES buffer (Invitro-
gen), Gentamicin (Sigma) and Penicillin–Streptomycin
(Invitrogen). Brain tissue was embedded in molten 4 %
Low Melting Point agarose (Seakem) in PBS at 43C with
stirring and was solidified on ice. Tissue was sectioned
coronally on a vibratome at a thickness of 300 lm. Slices
were collected into chilled 1 9 Kreb’s buffer with HEPES
and antibiotics. Brain slices were cultured in organ tissue
dishes containing 1 ml of medium (Neurobasal, Gibco)
supplemented with B-27, glutamine, glucose, penicillin,
and streptomycin. For transplantations, brain slices were
cultured in Millicell-CM 30 mm low height membrane
inserts (Millipore). Eminentia thalami were dissected out
from one or both sides of the brain of donor slices, and
transplanted to the ventral telencephalon of host slices.
Slices were re-incubated for between 24 and 48 h, after
which they were fixed in 4 % paraformaldehyde (PFA) in
0.1 M phosphate buffer (PB) overnight at 4C and pro-
cessed for immunohistochemistry or in situ hybridization.
For activation of Wnt/b-Catenin signalling in the ventral
telencephalon, slices were cultured on polycarbonate cul-
ture membranes (8 lm pore size; Corning Costar) in the
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presence of either 1 % dimethyl sulfoxide (DMSO) or of 5,
25 or 50 lM CHIR99021 (CHIR) (Cambridge BioS-
cience). Slices were cultured for 24 h, fixed as described
above, and processed for immunohistochemistry or in situ
hybridization as described below.
Histology, immunohistochemistry, in situ
hybridization
Embryos for gene expression analysis were collected from
E11.5 to E17.5. At least two embryos were analysed for
each age. Embryos were decapitated and the heads were
immersion fixed in 4 % PFA in 0.1 M PB overnight at 4C.
Cultured slices were fixed as described above.
Fixed tissues were processed for immunohistochemistry
or in situ hybridization following previously described
protocols (Fotaki et al. 2006, 2013).
For DAB and fluorescence immunodetection, antigen
retrieval was achieved by microwaving sections in 10 mM
sodium citrate buffer. Following DAB reaction, some
slides were counterstained with 0.5 % cresyl violet acetate
(Sigma). For immunofluorescence, species-specific sec-
ondary antibodies conjugated to Alexa fluor-488, 568 or
647 dyes (1:200, Invitrogen) were used to detect primary
antibodies. When signal amplification was required, sec-
tions were incubated with biotinylated secondary antibod-
ies. Antibody reactions were then revealed using
streptavidin–biotin complex conjugated to either 488 or
568 dyes (1:200, Invitrogen). Sections were counterstained
with DAPI (1:10000, Sigma). Antibodies used in this study
were mouse monoclonals for Ascl1 (1:200, BD Bio-
sciences), Lhx1 and Lhx5 (Lim1?2; 1:100, DSHB) and
Pax6 (1:200, DSHB); rabbit polyclonals for Calretinin
(1:1000, Swant), Lef1 (1:1000, Cell Signalling) and Tbr2
(1:1000, kindly provided by Prof. R. Hevner); a goat
polyclonal for GFP (1:500, Abcam) and a chick polyclonal
for GFP (1:200, AVES Labs).
For in situ hybridization, 1 lg of each linearized puri-
fied DNA template was transcribed using T3, T7 or SP6
RNA polymerase. RNA antisense probes were labelled
using the digoxygenin RNA labelling mix (Roche)
according to the manufacturer’s instructions. The following
riboprobes were used in this study: Bmp4, Bmp6, Fgf8,
Fgf15, Mkp3, Spry1, Wnt3a, Wnt7a, Wnt7b, Wnt8b, Wnt9a,
Axin2, Lef1, Sfrp2, Ngn2 and Foxg1.
Quantitation of Lef1-positive and Ascl11-positive
cells
To determine the effect of the different concentrations of
CHIR on Lef1 induction and upregulation as well as Ascl1
downregulation, Lef1-positive, Ascl1-positive and
Lef1;Ascl1-positive cells were counted in five representative
sections of every slide using the Image J 1.46r software
(NIH) and the mean determined (from fifteen sections
counted from three slices) for each of the concentrations
used. Means of the various concentrations were then com-
pared by a one-way Anova using the Graphpad Instat3.
P values less than 0.05 were considered significant.
Results
Analysis of expression of molecular markers
of the EmT
The EmT is a transient structure of the developing mam-
malian forebrain, which, in a coronal plane, is flanked dor-
somedially by the prethalamus and laterally by the choroid
plexus (Fig. 1a and Online Resource 3), while in a sagittal
plane the EmT lies caudal to the choroid plexus and rostral to
the prethalamus (Fig. 1b). To demarcate the EmT and gain a
better insight into how it changes during development, we
performed immunofluorescence and in situ hybridization
using markers that are expressed in this structure at different
developmental stages. At E12.5, double immunofluores-
cence for Pax6 and Calretinin revealed strong Pax6 staining
in the ventricular zone (VZ) of the EmT and the prethalamus
and Calretinin staining in the EmT cell fibres (Fig. 1c, d)
(Abbott and Jacobowitz 1999; Fotaki et al. 2006; Retaux
et al. 1999). Double immunofluorescence with an antibody
that recognises both Lhx1 and Lhx5 and Calretinin revealed
strong expression of Lhx1&5 in the layer of differentiated
neurons of the EmT that was also positive for Calretinin as
well as the VZ of the EmT (Fig. 1e, f). Double immunoflu-
orescence for the transcription factors Tbr2 and Ascl1
revealed Tbr2 expression in the layer of differentiated neu-
rons of the EmT,while Ascl1 expressionwas restricted to the
prethalamus (Fig. 1g). Ngn2 mRNA staining was found at
the VZ of the EmT but was not detected in the adjacent
prethalamus (Flames et al. 2007), thus allowing us to dis-
tinguish the medial boundary of the EmT (Fig. 1h, i).
At E14.5, the VZ of the EmT marked by strong Pax6
protein and Ngn2 mRNA was significantly thinner than that
observed at younger stages (Fig. 1j, k compare 1d to 1 j
and 1 h to 1 k). At E15.5 and E16.5, Pax6 and Ngn2
expression in this zone was each detected as a stripe of
staining ventral to the choroid plexus at all rostrocaudal
levels (arrows in Fig. 1l, m and not shown).
Expression of Wnt, Fgf and Bmp genes in the EmT
The hypothesis that the EmT acts as a signalling centre
predicts that it expresses one or more signalling molecules.
To examine this, we analysed the expression of members of
the Wnt, Fgf and Bmp families of signalling molecules.
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We first examined the expression of members of the
Wnt family of signalling molecules. Out of the nineteen
members, we examined the expressions of Wnt3a, Wnt7a,
Wnt7b, Wnt8b and Wnt9a which were more likely to be
expressed in the EmT based on results from database
searches (Genepaint: http://genepaint.org/; The Jackson
Laboratory: http://www.jax.org/; Allen Brain atlas: http://
www.brain-map.org/; EMAGE: http://emouseatlas.org/
emage/). In our study, we also included Axin2 and Lef1
which are downstream target genes of the pathway, and
Sfrp2, a negative regulator of the pathway (Hsu et al. 1998;
Jho et al. 2002; Porfiri et al. 1997). Expression was studied
along the rostrocaudal axis from E11.5 until gene expres-
sion was not evident. Unless otherwise stated, gene
expression for each specific gene was found along the
entire axis.
Results of in situ hybridization on E11.5 forebrain tissue
showed that at this stage the EmT expresses most of the
Wnt and Wnt-related genes analysed. Wnt7b mRNA
expression in the EmT was strong and involved the entire
thickness of the neuroepithelium. It extended from its
medial extent, where it was continuous with a similar
strong expression in the prethalamus, towards its lateral
aspects (Fig. 2a). Expression was detected in the cortical
hem of the dorsomedial telencephalon, but not in the
adjacent choroid plexus of the lateral ventricle (Fig. 2a).
Wnt8b mRNA was detected as a strong homogenous
staining involving the neuroepithelium of the EmT, the
choroid plexus of the lateral ventricle, the cortical hem and
the rest of the medial pallium (Fig. 2e). Expression in the
EmT appeared strong throughout, except at its most medial
bFig. 1 Expression of molecular markers of the EmT. a, b Schematic
representations of a coronal (a) and a sagittal section (b) of an E12.5
forebrain. The prethalamus (blue) is located dorsal (a) and medial
(b) to the EmT (green). Brown staining outlines the dorsomedial
telencephalon. In b and all following sagittal sections (d, f, i, j),
rostral is to the left and dorsal is to the top. c, d Pax6 (green) and
Calretinin (CR) (red) double immunofluorescence showing expres-
sion of these proteins in the EmT at E12.5. In both coronal (c) and
sagittal (d) sections, Pax6 is expressed in the proliferative layer while
CR is expressed by the postmitotic cells and fibres of the EmT. Pax6
is also expressed in the prethalamus. e, f Lhx1&5 (green) and CR
(red) immunofluorescence reveals strong Lhx1&5 expression in both
the proliferative and differentiating layers of the EmT at E12.5 in both
coronal (e) and sagittal sections (f). g Ascl1 (green) and Tbr2 (red)
immunofluorescence on coronal E12.5 sections reveals Tbr2 expres-
sion within the EmT. Ascl1 is found in the adjacent prethalamus. h,
i In situ hybridization for Ngn2 at E12.5 in both coronal (h) and
sagittal (i) sections. At this stage, Ngn2 mRNA expression distin-
guishes the EmT from both the prethalamus medially and choroid
plexus (arrowhead) laterally. j, l Expression of Pax6 (green) and CR
(red) in the EmT in a sagittal section at E14.5 (j) and a coronal section
at E15.5 (l). Pax6 and CR still mark the proliferative and postmitotic
layers, respectively. k, m Ngn2 expression is still seen in the
ventricular zone laterally (arrows) and medially, marking its bound-
ary with the choroid plexus and prethalamus, respectively, both in a
coronal section at E14.5 (k) and E15.5 (m). Blue colour in (l) is DAPI
used as counterstain. Abbreviations: CP choroid plexus, PTh
prethalamus, Th thalamus, Vtel ventral telencephalon, ZLI zona
limitans intrathalamica. Scale bars h, k = 250 lm; g, i, l and
m = 100 lm; c–f, j = 50 lm
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extent bordering the prethalamus (Fig. 2e). Weak Wnt9a
mRNA was detected in the lateral part of the caudal EmT
(Fig. 2i). Wnt3a and Wnt7a were not detected at this stage
(not shown). Axin2 mRNA expression in the EmT was
strong but was found only in the most lateral aspect of the
EmT (Fig. 2m). This strong expression was continuous
with a similar expression in the developing choroid plexus
and cortical hem in the dorsomedial telencephalon. Sfrp2
expression formed a high-medial to low-lateral gradient,
but did not involve the most lateral aspects bordering the
choroid plexus (Fig. 2u). Lef1 mRNA was not detected in
the EmT at this stage, but some mRNA was detected in the
prethalamus medial to it (Fig. 2q).
At E12.5, the genes detected at E11.5 were still
expressed in the EmT. The pattern and level of expression
of most of these genes at this stage were similar to those
observed at E11.5 (Fig. 2b, f, j, n, v). However, Wnt8b
mRNA expression in the EmT was no longer homogeneous
but formed a gradient with the highest levels detected in
the lateral EmT, and the lowest level in the medial part
bordering the prethalamus (Fig. 2f). Also, there was what
appeared to be a very weak Lef1 mRNA expression in the
caudo-lateral part of the EmT at this stage (Fig. 2r). In
addition, weak Wnt3a expression was detected in the most
lateral part of the EmT adjacent to the choroid plexus in the
middle and caudal sections (not shown). Wnt7a was also
detected at this stage in middle and caudal sections but,
unlikeWnt3a, it was detected in the medial half of the EmT
(not shown).
At E14.5, most expression patterns were similar to those
observed at E12.5 (Fig. 2c, g, k, o, s, w). However, for
Wnt7b, Wnt8b and Wnt9a, the strength of staining
appeared lower than that observed at younger stages
(Fig. 2c, g, k). The VZ marked by Wnt7b, Wnt8b, Axin2
and Sfrp2 also appeared thinner (Fig. 2c, g, o, w). Wnt3a
and Wnt7a were not detected in the EmT at E14.5 (not
shown).
Expression of Wnt7b mRNA was very weak in the EmT
at E15.5 (Fig. 2d) and E16.5 (not shown) and was not
identifiable at E17.5. Wnt8b, Wnt9a and Lef1 mRNA were
not detected in the EmT from E15.5 onwards (Fig. 2h, l, t).
Expression of Axin2 and Sfrp2 mRNAs in the EmT at
E15.5 appeared weaker than that observed at E14.5
(Fig. 2p, x) and was not detected beyond E15.5 (not
shown).
All the aboveWnt andWnt-related genes were expressed
in the VZ. Wnt7b showed an additional weak expression in
the mantle layer at E12.5 (Fig. 2b).
We then examined expression of members of the Fgf
and Bmp signalling pathways in the EmT (Fig. 3). Based
on the results using the same databases as for the study of
Wnts, we restricted our analysis to expression of two
members of each family: Fgf8 and Fgf15 for the Fgfs
(Fig. 3a–g) and Bmp4 and Bmp6 for the Bmps (Fig. 3n–s).
We also included in our study expression of Mkp3 and
Spry1, which are downstream targets of Fgf signalling
(Mason 2007; Suzuki-Hirano et al. 2010) (Fig. 3h–m).
At E11.5, the intensity of Fgf8 mRNA staining was high
in the rostral EmT (Fig. 3a), but low in the middle and
absent in the caudal EmT (not shown). Weak Fgf15 mRNA
expression was detected in the middle and caudal parts of
the medial EmT (Fig. 3e), but not in the rostral part. Mkp3
mRNA expression in the EmT was strong at all rostro-
caudal levels and appeared to form a high-medial to low-
lateral gradient (Fig. 3h). Spry1 mRNA was also found in
the entire neuroepithelium at all rostrocaudal levels of the
EmT, although expression was weak (Fig. 3k). The above
molecules were not detected in the neighbouring choroid
plexus and cortical hem. Bmp4 and Bmp6 were expressed
in the EmT, as well as the cortical hem, choroid plexus and
epithalamus. Expression in the EmT was weaker than that
detected in the epithalamus, and was confined to its most
lateral aspect bordering the choroid plexus (Fig. 3n, q).
At E12.5, the above described Fgf and Bmp genes were
still expressed in the EmT (Fig. 3b, f, i, l, o, r). Moreover,
the patterns of expression of these genes were similar to
those observed at E11.5. At E14.5, Fgf8, Mkp3, Spry1 and
Bmp4 were still expressed in the EmT (Fig. 3c, j, m, p).
However, the intensity of staining seen at this stage
appeared weaker and the VZ marked by these genes was
also thinner than seen at younger ages. Fgf15 and Bmp6
were not detected in the EmT at this stage (Fig. 3g, s). At
E15.5, only Fgf8 was still detected in the EmT (Fig. 3d).
To summarize, all the above members of the Wnt/b-
catenin signalling pathway were found in the VZ of the
EmT, where staining decreased as development progressed
and ceased for most of them by E15.5. Similar results were
obtained for the molecules of the Fgf and Bmp signalling
pathways, except that most of them were not detected
beyond E14.5. The above results are summarized in
Table 1.
Effects of small molecule activation of Wnt/b-catenin
signalling in the ventral telencephalon
Analyses of gene expression in the EmT showed some
distinct and some overlapping expression domains of Wnt,
Fgf and Bmp genes. The Wnt genes showed stronger
expression during EmT development compared to those of
the Fgf and Bmp families. For this reason, we chose to
follow up on the role of Wnt/b-catenin signalling pathway
in EmT function.
To examine whether the Wnt molecules expressed in the
EmT have a signalling capacity, we transplanted EmT
tissue into the ventral telencephalon to investigate if Wnt
signals from the EmT were able to induce any cell fate
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changes in this region (see following section). We chose
the ventral telencephalon as it normally does not express
significant levels of Wnt/b-catenin target genes (Backman
et al. 2005; Fotaki et al. 2011; Maretto et al. 2003).
Our first step was to test whether the ventral telen-
cephalon was competent to respond to Wnt/b-catenin
signalling. For this, we activated the pathway in telen-
cephalic slices by treating them in culture with three dif-
ferent concentrations of CHIR 99021 (CHIR) (5, 25 and
50 lM) in 1 % Dimethyl sulfoxide (DMSO) to dose-de-
pendently inhibit GSK3b activity. CHIR is a substituted
dihydropyromidine whose ability to inhibit GSK3b
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facilitates the cytoplasmic accumulation and subsequent
translocation to the nucleus of b-catenin, which is required
for the transcription of downstream targets of the Wnt/b-
catenin pathway (Ring et al. 2003). Our controls were
slices that were treated in culture with 1 % DMSO.
Lef1 is a transcriptional activator in the Wnt/b-catenin
signalling pathway (Hsu et al. 1998; Porfiri et al. 1997) and
is expressed in the thalamus and the dorsal and dorsomedial
telencephalon (Fig. 4a, a1) (Fotaki et al. 2011; Galceran
et al. 2000). DAB immunohistochemistry with an antibody
for Lef1 revealed a small number of Lef1-positive cells in
the VZ of the lateral ganglionic eminence (LGE), located at
a distance from the pallial–subpallial boundary (PSPB)
(Fig. 4a, a1). These cells express very low levels of Lef1
compared to the Lef1 heavily stained cells in the dorsome-
dial telencephalon (Fig. 4a1) and were not detectable using
Lef1-immunofluorescence (not shown). To determine the
level of activation of Wnt/b-catenin signalling in the ventral
telencephalon, we analysed in both control and experimental
slices Lef1 expression in this region.
In DMSO-treated slices, Lef1 expression was detected
in the VZ of the LGE (Fig. 4b, b1) at a similar position to
that described above (Fig. 4a, a1). However, expression
was stronger compared to non-treated sections (compare
Fig. 4b1 to 4a1), but it was still lower than Lef1 expression
in the dorsomedial telencephalon from the same section
(Fig. 4b, b1). A mean of 245.13 (±SD = 38.02) Lef1-
positive cells per section was counted in the ventral
telencephalon of these control slices (Table 2).
In both 5 lM and 25 lM CHIR-treated slices, strong
Lef1 expression was detected in the VZ and the superficial
mantle layer of the ventral telencephalon (Fig. 4c, d). The
intensity of staining seen in the ventral telencephalon at
these two concentrations was similar to each other and
appeared higher than that seen in DMSO-treated slices
(compare Figs. 4c1 and d1 to 4b1). Cell counts revealed a
statistically significant increase of 39 % (P\ 0.001) and
60 % (P\ 0.001) in Lef1-positive cells in slices treated
with 5 and 25 lm CHIR, respectively, compared to the
control group (Table 2). In 50 lM CHIR-treated slices,
very strong Lef1 expression was detected in the VZ as well
as in the mantle layer of the ventral telencephalon (Fig. 4e,
e1). Moreover, Lef1 expression in the VZ involved its
entire mediolateral extent, and included the PSPB
(Fig. 4e1). Numbers of Lef1-positive cells in the ventral
telencephalon were *192 % greater than those found in
the control (P\ 0.001) (Table 2). These results confirm
that the ventral telencephalon is competent to respond to
Wnt/b-catenin signalling.
We then examined the expression of Foxg1 and Ascl1 to
study how the increase in Lef1 staining in the ventral
telencephalon may affect distribution of these proteins in
this region. In wild types after E12.5, Foxg1 is detected at
high levels in both the dorsal and ventral telencephalon
(Fotaki et al. 2006; Hanashima et al. 2002; Tao and Lai
1992; Xuan et al. 1995), while Ascl1 is expressed at high
levels in the ventral telencephalon (Guillemot and Joyner
1993; Lo et al. 1991; Porteus et al. 1994).
In both DMSO and CHIR-treated slices, Foxg1 was
expressed in the entire ventral telencephalon forming a
gradient, with expression in the VZ being higher than
expression in the mantle layer (not shown). Also, the
intensity of Foxg1 staining seen in sections of all CHIR-
treated slices was similar to that seen in DMSO-treated
slices (Fig. 4f–h). Lef1 expression was as described earlier
for each of the concentrations used. In both DMSO and
CHIR-treated slices, Lef1 was detected in the nuclei of
some cells in the VZ and the mantle layer of the ventral
telencephalon. In these cells, the Lef1-positive nuclei
(brown stain in Fig. 4f–h) were surrounded by cytoplasmic
Foxg1 mRNA (purple stain in Fig. 4f–h).
In both control and experimental groups, Ascl1-positive
cells were detected in the VZ and mantle layer of the
ventral telencephalon at all rostrocaudal levels (Fig. 4i–l).
Ascl1 expression extended medially from the subpallial
side of the PSPB and included the entire mediolateral
extent in both zones. However, the number of cells
expressing Ascl1 differed from one group to the other
(Table 3). A mean of 215 (±SD = 44.71) Ascl1-positive
cells per section was counted in the ventral telencephalon
of DMSO-treated slices. In the VZ, a few of these Ascl1-
positive cells were also Lef1-positive, but the majority
were single-labelled (Fig. 4i2). Ascl1-positive cells in the
mantle layer were all single-labelled. In 5 lM CHIR-
treated slices, Ascl1 expressing cells present in the ventral
telencephalon were *3 % fewer than those counted in
DMSO-treated slices and this difference was not statisti-
cally significant (Table 3). Many of the Ascl1-expressing
cells detected were single-labelled (Fig. 4j2). In 25 and
bFig. 2 Expression of Wnt and Wnt-related genes in the EmT from
E11.5. a–d Wnt7b expression. Strong Wnt7b mRNA is detected in the
EmT at E11.5 (a) and 12.5 (b) and is downregulated at E14.5 (c) and
E15.5 (arrowhead in d). e–h Wnt8b expression. Strong Wnt8b mRNA
is detected from 11.5 to 14.5 (e–g), after which it is no longer
detectable in the EmT (h). i–l Wnt9a expression. Weak Wnt9a mRNA
is detected in the caudo-lateral EmT from E11.5 to E14.5 (i–k), after
which it is no longer detected (arrowheads in l mark the lateral limit
of the EmT at E15.5). m–p Axin2 expression. Axin2 mRNA
expression is seen in the lateral aspect of the EmT from E11.5 to
E15.5. q–t Lef1 expression. At E11.5 (q), Lef1 mRNA is not detected
in the EmT, but it is found in the prethalamus medial to it. From
E12.5 to E14.5 (r, s), very weak Lef1 mRNA is detected in the lateral
aspect of the EmT (arrowheads). This weak expression is not detected
from E15.5 onwards (t). u–x Sfrp2 expression. Strong Sfrp2 mRNA is
detected in the EmT from E11.5 to E14.5 (u–w), and becomes weak
at E15.5 (arrowhead in x). Abbreviations: CP choroid plexus, PTh
prethalamus, Th thalamus, Vtel ventral telencephalon. Scale bars d, h,
l, p = 200 lm; a–c, e–g, i–k, m, n, r–t, v, w = 100 lm; u,
x = 50 lm; q = 25 lm
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Fig. 3 Expression of Fgf and Bmp-related genes in the EmT from
E11.5 to E15.5 a–d Fgf8 expression. Strong Fgf8 mRNA expression
detected in the EmT at E11.5 (a) and 12.5 (b), is downregulated at
E14.5 (c) and E15.5 (d). e–g Fgf15 expression. Fgf15 mRNA is
detected in the middle and caudal EmT at E11.5 (e) and E12.5 (f) but
is no longer detectable in the EmT at E14.5 and beyond (g). h–
j Strong Mkp3 mRNA is expressed in the entire rostrocaudal extent of
the EmT till E14.5. Sections shown are from the middle portion of the
EmT. k–m Spry1 mRNA is expressed in the EmT from E11.5 to
E14.5. n–p Bmp4 mRNA expression is detected in the most lateral tip
of the EmT till E14.5. q–s Bmp6 mRNA is expressed in the lateral
EmT at E11.5 and E12.5 but not at E14.5 (arrowhead in s). Scale bars
b, j, l, m, r = 200 lm; a, c–i, k, n–p, q, s = 100 lm
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50 lM CHIR-treated slices, Ascl1-positive cells were sig-
nificantly reduced by *46 % (P\ 0.001) and 62 %
(P\ 0.001), respectively, compared to the number found
in the control group (Table 3). The number of Lef1;Ascl1
double-labelled cells was not different between control and
DMSO-treated slices (Table 4).
These results confirm that the ventral telencephalon is
competent to respond to Wnt/b-catenin signalling as shown
by the increased expression of Lef1. In addition, this Lef1
upregulation leads to a decrease in the number of Ascl1-
positive cells that are normally expressed in the ventral
telencephalon.
The EmT induces cell fate changes in the ventral
telencephalon
To test whether signals from the EmT are capable of
inducing cell fate changes similar to those observed when
Wnt/b-catenin signalling is upregulated in the ventral
telencephalon, EmT tissue from tau-GFP transgenic mice
(donor) that ubiquitously express GFP (Pratt et al. 2000)
and, therefore, allowed a distinction between donor and
host tissue was transplanted into the ventral telencephalon
of wild type CD1 mice (host) in culture. The hosts were
then analysed for expression of Lef1, Foxg1 and Ascl1 in
the ventral telencephalon.
Two groups of EmT transplants were used. One group
consisted of 10 slices, each hosting one piece of EmT
explant in the ventral telencephalon (Fig. 5d, Group 1).
The other group was made up of 10 slices with two EmT
explants each (Fig. 6a, Group 2). To control for the
specificity of the effects of the EmT tissue in the ventral
telencephalon, an additional group of 10 slices each hosting
two pieces of cortical explants from the middle third of the
dorsolateral telencephalon, where Lef1 expression is very
weak, was included in the study (Fig. 5a, Control group).
In all three groups, the explants were placed in one
hemisphere, and the opposite hemisphere was used as
control. To confirm the location of the explants in the hosts,
the slices were examined for GFP expression (green
staining in Figs. 5, 6). Additionally in cultures hosting
EmT explants, Calretinin immunofluorescence was done to
confirm that they were indeed EmT tissue (Fig. 6b, b1 and
not shown).
Double immunofluorescence for GFP (green) and Lef1
(red) revealed that in the control group, Lef1 was not
detected in the ventral telencephalon of 9/10 slices
(Fig. 5b, b1, b2). In 1/10 of slices analysed (Fig. 5c), Lef1-
positive cells were seen in parts of the VZ, though no
positive cells were detected in the mantle layer.
Similarly, in cultured slices hosting one EmT explant,
Lef1 was not detected in the ventral telencephalon of 9/10
of the slices (Fig. 5e, e1, e2). In only 1/10 of slices anal-
ysed, the Lef1-immunoreactive cells were present in the
VZ but not in the mantle layer, as indicated by arrowheads
in Fig. 5f.
It should be noted that in some cases Lef1 expression
was also observed in the VZ of the ventral telencephalon of
the control hemisphere with no explant present (arrowhead
in Fig. 6e). This is in line with Lef1 expression detected in
a group of slices cultured without explant. In 4/20 of these
control slices, Lef1 was detected in the VZ of the ventral
telencephalon, either on one or both halves of the brain, but
it was never observed in the mantle layer (not shown).
In cultured slices hosting two EmT explants, Lef1
staining was detected in the ventral telencephalon in 9/10
of slices analysed. In 2 of these 9 slices, the Lef1-positive
cells were only found at the VZ and were not observed in
Table 1 Summary of gene expression in the EmT along the rostrocaudal axis
Bmp4 Bmp6 Fgf8 Fgf15 Mkp3 Spry1 Wnt7b Wnt8b Wnt9a Axin2 Lef1 Sfrp2
E11.5 R ? ? ?? n.d ?? ? ??? ??? n.d ?? n.d ??
M ? ? ? ? ?? ? ??? ??? n.d ?? n.d ??
C ? ? n.d ? ?? ? ??? ??? ? ?? n.d ??
E12.5 R ? ? ?? n.d ?? ?? ??? ??? n.d ?? n.d ???
M ? ? ? ? ?? ?? ??? ??? n.d ?? n.d ???
C ? ? n.d ? ?? ?? ??? ??? ? ?? ? ???
E14.5 R ? n.d ? n.d ? ? ?? ?? n.d ?? n.d ??
M ? n.d ? n.d ? ? ?? ?? n.d ?? n.d ??
C ? n.d n.d n.d ? ? ?? ?? ? ?? ? ??
E15.5 R n.d n.d ? n.d n.d n.d ? n.d n.d ? n.d ?
M n.d n.d ? n.d n.d n.d ? n.d n.d ? n.d ?
C n.d n.d n.d n.d n.d n.d ? n.d n.d ? n.d ?
Legend: R rostral, M middle, C caudal, n.d. not detected, ? weak, ?? strong, ??? very strong
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the mantle layer (not shown). In 7 of the 9 slices, the Lef1-
positive cells were present in the VZ, as well as the mantle
layer (Fig. 6c, c1, c2, e, e1). Lef1-positive cells were found
in sections where the explants were present, as revealed by
their GFP immunoreactivity (compare position of explant
in Fig. 6b, c), and were located around the explants
(Fig. 6c, c1, c2). These Lef1-positive cells were GFP-neg-
ative (Lef1 brown staining in Fig. 6c1 and c2 is found
outside the explant, the GFP-positive area shown in
Fig. 6b1). Lef1-positive cells were also found in the VZ
and the mantle layer of the ventral telencephalon of sec-
tions where no more tissue from the explant could be
detected with GFP immunostaining and as before, these
Lef1-positive cells were GFP-negative (Fig. 6e, e1). The
fact that Lef1-expressing cells present in the mantle layer
of the ventral telencephalon were GFP-negative indicates
that these cells are unlikely to be donor cells and may be
ventral telencephalic cells induced to express Lef1.
To gain further insight into the identity of these Lef1-
expressing cells, we examined whether they expressed the
ventral telencephalic marker Ascl1. In sections containing
EmT explants, Ascl1 staining was not seen in the explants
but was found in cells surrounding them, as shown in
Fig. 7c and illustrated in Fig. 7a. Normal expression of
Ascl1 and Lef1 was observed in the cultured half of the
brain with no explant (not shown). In sections with
explants containing Lef1-induced cells, the Lef1-positive
cells mingled with the Ascl1-positive cells (Fig. 7d, d1 and
illustrated in Fig. 7a). Figure 7d and d1 depicts sections of
bFig. 4 Effect of Wnt/b-catenin signalling upregulation on gene
expression in the ventral telencephalon. a, a1 Lef1 expression in the
ventral telencephalon of CD1 mice at E 13.5. Lef1 is strongly
expressed in the dmt and Th. Arrowheads in a1 point to faintly
expressing Lef1-positive cells detected in the VZ of the ventral
telencephalic LGE and at a distance from the PSPB (indicated by an
arrow). a1 is a magnification of a. b–e Lef1 expression in the ventral
telencephalon of treated slices. b, b1 Lef1 expression in DMSO-
treated slices. Lef1 is detected in parts of the VZ and superficial
mantle layer. Staining is not seen at the PSPB but at some distance
away from it, as shown with arrowheads in b1. c, c1 Lef1 expression
in slices treated with 5 lM CHIR and (d, d1) 25 lM CHIR. A fairly
strong Lef1 expression is seen in the ventral telencephalon. Lef1
expression marks almost the entire VZ and superficial mantle layer
beginning from the subpallial side of the PSPB. The arrows in d1
point to blood vessels found in the mantle. e–e1 Lef1 expression in
50 lm CHIR-treated slices. Very strong Lef1 expression is detected
in the ventral telencephalon. Several Lef1-positive cells are seen in
the VZ and mantle layer of the ventral telencephalon. In the VZ, Lef1
is also expressed in the PSPB (arrowhead in e1). b1, c1, d1 and e1 are
magnifications of the regions indicated in b, c, d and e, respectively.
f–h Lef1 and Foxg1 expression in treated slices. In both control
(f) and CHIR-treated groups (g, h) Foxg1-positive cells (blue-in situ
hybridization staining) in the ventral telencephalon also express Lef1
(brown-DAB staining). i–l Lef1 and Ascl1 expression in the ventral
telencephalon of treated slices. i, i1 and i2 In DMSO-treated slices,
Ascl1 is detected in the VZ and mantle layer of the ventral
telencephalon. A few Lef1-positive cells are detected within these
zones (i, i1). Most of the Lef1-positive cells are Ascl1-negative and
only a few are double-labelled (arrowheads in i2). j, j1 and j2 Lef1
and Ascl1 expression in 5 lM CHIR-treated slides. Several Ascl1-
expressing cells are detected in the VZ and mantle. The intensity of
staining seen in many of the cells is similar to that seen in i. Many of
the cells are single-labelled (j2). k, k1 and k2 Lef1 and Ascl1
expression in 25 lM CHIR-treated slides. Fewer Ascl1-expressing
cells than those detected in i and j are seen in the VZ and mantle
layer. l, l1 and l2 Lef1 and Ascl1 expression in 50 lM CHIR-treated
slides. Very few Ascl1-positive cells are seen in the VZ and mantle
layer of the ventral telencephalon. On the other hand, many Lef1-
expressing cells are detected in these zones, many of which are Ascl1-
negative. Abbreviations: dmt dorsomedial telencephalon, LGE lateral
ganglionic eminence, PSPB Pallial–Subpallial Boundary, Th Thala-
mus, VZ Ventricular zone. Scale bars b–e, k–n = 250 lm; a, b1–e1,
i1–l1 = 50 lm, a1, f–h, i2–l2 = 20 lm
Table 2 Lef1-positive cells in the ventral telencephalon of treated
slices
Lef1-positive cells per section
Mean STDEV % increase P value
DMSO 245.13 38.02 N/A N/A
5 lM CHIR 340.80 45.56 39.03 \0.001
25 lM CHIR 391.33 37.87 59.64 \0.001
50 lM CHIR 715.80 102.18 192.00 \0.001
Shown are the mean number of cells per section with the standard
deviation (STDEV), the % increase in number of Lef1-positive cells
compared to the control (DMSO) group and the P values of each
group compared to the control
Table 3 Ascl1-positive (?) cells in the ventral telencephalon of
treated slices
Ascl1-positive cells per section
Mean STDEV % Ascl1-? P value
DMSO 215.40 44.71 100.00 N/A
5 lM CHIR 209.60 28.76 97.31 [0.05
25 lM CHIR 115.60 12.35 53.67 \0.001
50 lM CHIR 82.27 11.63 38.19 \0.001
Shown are the mean number of cells per section with the standard
deviation (STDEV), the % number of Ascl1-positive cells and the
P values of each group compared to the control (DMSO) group
Table 4 Lef1 and Ascl1 (Lef1;Ascl1) double-positive cells in the
ventral telencephalon of treated slices
Lef1;Ascl1-positive cells per section
Mean STDEV P value
DMSO 12.33 3.31 N/A
5 lM CHIR 13.83 4.37 [0.05
25 lM CHIR 14.08 4.08 [0.05
50 lM CHIR 14.25 5.10 [0.05
Shown are the mean number of cells per section with the standard
deviation (STDEV) and the P values of each group. No significant
differences are observed
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Fig. 5 Lef1 expression in the ventral telencephalon of cultured slices
hosting two cortical explants (a–c) and one EmT explant (d–f). a A
schematic representation of Lef1 expression in slices hosting two
cortical explants. The region of the tau-GFP donor tissue from which
cortical explants were taken from is shown in green. In 9/10 of slices
analysed, Lef1 staining was not seen in the ventral telencephalon. In
the remaining 1/10 slices, Lef1 staining was seen in the ventricular
zone but not in the mantle layer. b, c Sections of two slices from this
group with two tau-GFP-positive cortical explants each on the left
hemisphere. b1 is a higher magnification of b and b2 is a section from
the same slice. Superficial is to the left. In b1 and b2, Lef1 staining is
not seen in the ventral telencephalon. In c, Lef1-positive cells
(arrowheads) are seen in the ventricular zone but not in the mantle
layer. d A schematic representation of Lef1 expression in slices
hosting one EmT explant from a tau-GFP donor is shown in green. In
9/10 of slices analysed, Lef1 was not detected in the ventral
telencephalon. However, in the remaining slice Lef1 staining was
seen in the ventricular zone of the ventral telencephalon, but not in the
mantle layer. e, f Sections from cultured slices hosting one tau-GFP-
positive EmT explant (green) on the left half of the brain. e1 and e2
are serial sections of e. Lef1 staining is not detected in these sections.
In e2, very little of the explant remains. In f, Lef1 staining is seen in
the ventricular zone around the explant (arrowheads). The dashed
curves delineate the limits between the ventral telencephalon and the
thalamus and/or dorsal telencephalon. The arrows in b2, c and e2 mark
the CP, which shows intense yellow non-specific staining. Abbrevi-
ations: CP choroid plexus, EmT Eminentia thalami, dmt dorsomedial
telencephalon, nctx neocortex, PTh prethalamus, Th thalamus, Vtel
ventral telencephalon. Scale bars b = 250 lm, b1, b2, = 100 lm; c,
e1, e2, f = 50 lm
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the slice culture located deep within the explant. The
position of the explant for those sections is shown in
Fig. 7b–b3. High power confocal images for these slice
explants immunoreacted with Ascl1 and Lef1 showed that
most of these cells either expressed Lef1 or Ascl1
(Fig. 7e1–e4). Further analysis of the identity of the Lef1-
positive cells using in situ hybridization for Foxg1 revealed
that the Lef1-expressing cells in the ventral telencephalon
also expressed Foxg1 (not shown).
We further examined whether the Lef1-positive cells
induced in the ventral telencephalic tissue surrounding the
explant expressed the dorsal telencephalic marker Pax6.
Lef1-positive cells intermingling with Ascl1-positive cells
located lateral to the explant in Fig. 7f1 were
immunonegative for Pax6 (not shown). However, a group
of Lef1-positive cells located dorsal to this explant
(Fig. 7f1, f2), in a region that does not normally express
Pax6, were also positive for Pax6 (Fig. 7f3, f4). Interest-
ingly, at this location which would not normally express
Ascl1 either, no Ascl1-positive cells were observed (not
shown). This suggests that the molecular fates of cells
affected by the explant might depend on their location and
pre-existing molecular state.
All together, the above results indicate that EmT tissue
has the capacity to activate Wnt/b-catenin signalling in the
ventral telencephalon, a brain region where it is not nor-
mally active, and to suppress expression of the ventral
telencephalic marker Ascl1. Abnormal expression of Pax6
in the ventral telencephalon suggests that the presence of
EmT may, in certain circumstances, cause the ventral
telencephalon to adopt a dorsal fate.
Discussion
The EmT is a diencephalic structure that lies between the
choroid plexus of the lateral ventricle and the prethalamus
(Puelles and Rubenstein 2003 and Fig. 1). Although its
location has been carefully mapped in vertebrates, includ-
ing humans, using anatomical landmarks and gene
expression patterns (Abellan et al. 2010; Fotaki et al. 2006,
2008; Puelles et al. 2000; Retaux et al. 1999; Roy et al.
2014), little is known about its function. In contrast to non-
mammalian EmT, which has been identified both during
development and in adults (Wullimann and Mueller 2004),
the mammalian EmT seems to be a transient developmental
structure (Keyser 1972). Based on its transient appearance,
characterized by strong calretinin immunoreactivity which
becomes undetectable after E17.5, Abbott and Jacobowitz
(1999) suggested that the EmT may act as diencephalic
organizing centre. A recent study suggested that the cor-
tical hem, ventral telencephalic septum, and EmT may act
as a multicomponent patterning and organizing centre for
the medial forebrain (Roy et al. 2014). Here, we examine
the molecular and cellular properties of the EmT and
provide strong evidence that is in line with the notion that
this transient developmental mammalian structure may act
as a signalling centre of the developing forebrain.
Our detailed analysis of expression of members of the
Wnt, Bmp and Fgf gene families in the developing EmT
revealed that, indeed, this structure is rich in expression of
signalling molecules. For most of these molecules,
expression was detected in the proliferative layer of the
EmT at around E11.5 and ceased by E15.5, when most of
the progenitor cells have differentiated into neurons, as
reflected by the thinning of the size of the ventricular zone
and the thickening of Calretinin staining. Unlike the
neighbouring cortical hem, a secondary organizer of the
hippocampal primordium (Mangale et al. 2008), which
displays strong expression for bothWnt and Bmp molecules
(Grove et al. 1998), the EmT showed strong expression for
Wnts but low levels of expression for members of the Bmp
family. Fgfs showed restricted expression in the EmT but
expression of Mkp3, a downstream negative regulator of
Fgf signalling (Li et al. 2007), was more widespread. This
compares to the restricted expression of Fgf8 in relation to
the widespread expression domain of Mkp3 in the isthmus
(Echevarria et al. 2005), a secondary organizer of the
midbrain–hindbrain region (Martinez 2001).
In addition to strong expression of Wnt molecules,
mainly Wnt7b and Wnt8b, the EmT showed expression of
downstream targets of the Wnt/b-catenin pathway such as
Axin2 and Lef1. Axin2, although strong, was only found in
the most lateral aspect of the EmT in its entire rostrocaudal
axis. This restricted expression may be due to the strong
expression of Sfrp2, an antagonist of Wnt signalling
(Wawrzak et al. 2007), expressed in a high-medial to low-
lateral gradient complementary to that of Axin2. Very low
Lef1 expression in the EmT with high levels in the
neighbouring prethalamus resembles lack of Lef1 expres-
sion in the cortical hem with high expression levels in the
adjacent dorsomedial pallium (Fotaki et al. 2011; Galceran
et al. 2000).
Can the secreted proteins found to be expressed in the
EmT elicit a signalling response? The fact that our
heterotopic explants of EmT donor tissue within the ventral
telencephalic host led to upregulation of Lef1 in the sur-
rounding ventral telencephalon in 9/10 of slices examined
favours our hypothesis that signals emitted from the EmT
may affect the fate of surrounding cells. Although very
faintly Lef1-expressing cells were detected in the VZ of the
ventral telencephalon in wild type embryos, none were
found in the mantle layer. In contrast, the Lef1-expressing
cells around the explant were strongly expressing cells and
in 7/10 cases they were not restricted to the VZ, but were
also found in the mantle layer, strongly indicating that the
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grafted EmT induces production of these cells. The use
of tau-GFP mice that express ubiquitously GFP (Pratt
et al. 2000) allowed us to unequivocally distinguish
donor from host tissue. Although the EmT has been
previously shown to be a source of neurons that migrate
to the ventral forebrain (Tissir et al. 2009), in our case
the Lef1-positive cells were GFP-negative, indicating
that it is unlikely that these cells are EmT-migrating
cells. As we only observed Lef1 upregulation in the VZ
in 1/10 of control cases that involved transplanted cor-
tical tissue in the ventral telencephalon, we are confident
that our results are specific to EmT activity on the host
environment rather than the outcome of a stochastic
event. It is noteworthy that the effect of the EmT on the
host tissue was only observed when two EmT pieces
were grafted. It may be that although the EmT possesses
an apparent ability to induce Lef1 in the ventral telen-
cephalon ex vivo, under our experimental conditions the
level of signal(s) secreted by one piece of EmT tissue
does not reach the required threshold for this induction to
take place.
It is also possible that the effect exerted on the sur-
rounding tissue depends on the position of the explant. In
the current experimental design, the explants were placed
away from the VZ but placing them nearer to it might have
led the EmT donor-emitted Wnt signals to cause a more
profound effect on the surrounding tissue than the one we
have currently observed. This is in line with the fact that in
our CHIR-induced cultures we observed a clearer upregu-
lation of Lef1-positive cells in the VZ rather than the
mantle region.
Based on the fact that among the signalling factors we
studied, Wnt7b and Wnt8b displayed the most robust and
prolonged expression, we hypothesized that the primary
pathway activated by the EmT is the Wnt/b-catenin sig-
nalling cascade. In cultured ventral telencephalic slices,
where Wnt/b-catenin signalling was activated by inhibition
of Gsk3b activity (van Noort et al. 2002), Lef1 expression
increased with an increased inhibition of this activity. The
high levels of Lef1 expression in DMSO-treated slices have
been previously observed in other culture systems sug-
gesting that DMSO per se may activate Wnt/b-catenin
signalling (Nakamura et al. 2003; Peng et al. 2002).
However, these were significantly lower than the number
of Lef1-expressing cells observed with even the lowest
concentration of drug activator, confirming that the sig-
nificant increase in Lef1-expressing cells in the ventral
telencephalon was the result of a specific activation of the
Wnt/b-catenin pathway. Although some of the Lef1-posi-
tive cells co-expressed Ascl1, the number of these
Lef1;Ascl1-positive cells was very small and remained
unchanged among all treated conditions and the control
group, suggesting that these double-labelled cells may
account for the low number of Lef1-positive cells normally
found in the ventral telencephalon.
The dose-dependent induction of Lef1 in these ventral
slices was concomitant with a significant dose-dependent
decrease in Ascl1 expression, strongly suggesting that Lef1
upregulation in the ventral telencephalon leads to a sup-
pression of ventral fates. Similarly, when the induced Lef1-
positive cells in our explant experiment were examined for
expression of the ventral telencephalic marker Ascl1 and the
telencephalic marker Foxg1, it was found that these cells
were Ascl1-negative;Foxg1-positive. Thus, results of these
two different experimental approaches suggest that Wnt/b-
catenin signalling may lead to a cell fate change in the
surrounding tissue. It is worth noting that some of the Lef1-
induced cells were in deeper positions, relative to the VZ
apical surface, than those that showed induction in the
CHIR-treated explants. One likely explanation for this is that
the EmT grafts produce signalling molecules additional to
Wnts such as Fgfs and Bmps, which may affect exactly
which cells undergo Lef1 activation in the host tissue.
If the EmT-derived signals inhibit Ascl1-expressing
cells, why are there still a lot of Ascl1-positive cells sur-
rounding the EmT explants? We propose that the EmT-
secreted signals are able to affect the fate of some cells
which respond to those signals by upregulating Lef1. One
cFig. 6 Lef1 expression in the ventral telencephalon of cultured slices
hosting two EmT explants. a A schematic representation of Lef1
expression in this group. The region of the tau-GFP donor tissue from
which the two EmTs were taken from is shown in green. In 1/10 of
slices analysed, Lef1 was not detected in the ventral telencephalon; in
2/10 slices, Lef1 was seen only in the ventricular zone (VZ); and in
7/10 slices, Lef1 was seen in the VZ and mantle layer. (b) Double
immunofluorescence for GFP (green) and Calretinin (CR) (red) on a
section from a cultured slice hosting two EmT explants (asterisk) on
the left half of the brain. b1 is a magnification of the region indicated
in b. The explants are both GFP and Calretinin positive confirming
that these are EmT tissue. c Lef1 immunohistochemistry (brown
staining) counterstained with cresyl violet (blue staining) on a
consecutive section to that shown in b reveals staining in cells
peripheral to the explants (green arrowhead). These Lef1-positive
cells surrounding the explants are not GFP-positive as inferred from
their positions in b1 (white arrowheads) and c1 (green arrowheads).
b1 and c1 are magnification of the regions indicated in b and c,
respectively. c2 is a magnification of the region indicated in c1. d and
e are serial sections from a slice hosting two EmT explants on one
half of the ventral telencephalon. In e, where there is no EmT explant
remaining, Lef1 staining is found in the VZ and mantle layer. The
arrowhead points to Lef1 expression limited at the ventricular zone of
the untreated hemisphere. e1 is a magnification of the Vtel shown in e.
Lef1-positive cells found in the ventral telencephalon (arrowheads)
are not GFP-positive suggesting that they may be host cells. The
section is counterstained with DAPI (blue). The dashed curves
delineate the limits between the ventral telencephalon and the
thalamus and/or dorsal telencephalon. Abbreviations: CP choroid
plexus; dmt dorsomedial telencephalon, EmT eminentia thalami; nctx
neocortex; PTh prethalamus, Th thalamus, Vtel ventral telencephalon.
Scale bars b, c, d, e = 250 lm; b1, c1, e1 = 50 lm; c2 = 20 lm
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reason that some cells do not respond by upregulating Lef1
may be that their state of differentiation renders them
unresponsive to the signal. Alternatively, the levels of
signal reaching each cell may differ among cells due to
their precise position and the nature of the diffusion of the
signal from the EmT explant. In addition, as discussed
above, the EmT expresses different secreted factors along
its rostrocaudal and medio-lateral axis and their expression
levels change during embryonic development. In line with
this dynamic spatio-temporal expression, EmT cells may
elicit a different response at different positions in the sur-
rounding tissue due to spatial variation in the cocktail of
molecules produced by the explants and/or in the relative
amounts of these secreted factors.
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In agreement with the role of Wnt/b-catenin signalling
in dorsal telencephalic specification (Backman et al. 2005;
Gunhaga et al. 2003) and the fact that constitutive
expression of b-catenin in the mouse ventral telencephalon
leads to its partial dorsalization with a concomitant
repression of ventral telencephalic markers (Backman et al.
2005), it is possible that these Lef1-positive cells have
acquired dorsal telencephalic identity. This is further sup-
ported by the upregulated expression of the dorsal telen-
cephalic marker Pax6 within the ventral telencephalon
adjacent to the EmT explant. It is intriguing that this Pax6
expression was observed in cells ectopically expressing
Lef1 that were not surrounded by Ascl1 expressing cells
but was absent from Lef1-positive cells surrounded by
Ascl1-positive cells. Further studies with additional
markers will be needed to test further the identities of the
EmT-induced Lef1-positive cells within the ventral telen-
cephalon and to allow us to understand the necessary
conditions that trigger those identities.
A self-evident question that this study raises is that if the
EmT plays a role as signalling centre, which are the
domains it exerts its signalling activity on? Signalling
centres usually lie at the borders of the regions they specify
(Kiecker and Lumsden 2005). As the EmT lies between the
choroid plexus of the lateral ventricle, the ventral telen-
cephalon and the prethalamus, an attractive hypothesis is
that it may pattern these regions (Online Resources 1, 2
&3). The phenotypic defects observed in mouse mutants
with abnormal EmT structures favour this hypothesis. In
the Gli3 mutant, EmT cell clusters intermingle with dorsal
telencephalic cells possibly as a result of abnormal for-
mation of the telencephalic-diencephalic boundary (Fotaki
et al. 2006). In addition, in Gli3 chimaeras the EmT seems
to become duplicated near the telencephalic–diencephalic
border, where nearby cells express abnormal sets of tran-
scription factors—cells lying on the telencephalic side of
the boundary express diencephalic markers (Quinn et al.
2009). In the Lhx2 mutant, the EmT expands at the expense
of the caudal ganglionic eminence, leading to the hypoth-
esis that the EmT may act as the diencephalic hem to
regulate key aspects of forebrain patterning and develop-
ment (Roy et al. 2014). In the Olig2 mutant, the EmT is
expanded at the expense of a hypoplastic prethalamus (Ono
et al. 2014). In all the above examples, changes in the
mutant EmT are concomitant with significant changes in
the above-mentioned neighbouring forebrain tissue.
Our findings show that the EmT not only expresses Wnt
molecules but also activates Wnt/b-catenin signalling. At
present, we can only hypothesize about the forebrain areas
to which the EmT Wnts may be signalling. Based on the
fact that b-catenin promotes and maintains thalamic fate
but prevents prethalamic fate (Bluske et al. 2012), it is
unlikely that EmT-derived Wnt/b-catenin signals target the
neighbouring prethalamus. An attractive hypothesis is that,
similar to the Wnt-rich cortical hem which has been pro-
posed to affect choroid plexus development (Grove et al.
1998), Wnt signals from the EmT also affect formation
and/or function of the adjacent choroid plexus. This is in
line with the fact that already at 8 somites, before choroid
plexus formation, a Wnt7b/Wnt8b rich domain defines a
region of the prosencephalon that probably corresponds to
the future EmT and adjacent cortical hem (Fotaki et al.
2011).
A comprehensive fate map of the mammalian EmT has
not been reported to date. It has been shown that pioneer
neurons from the mouse EmT migrate to the ganglionic
eminences and the marginal zone of the cortex (Morante-
Oria et al. 2003) and also form part of the ventral forebrain
(Tissir et al. 2009). It has also been reported that the EmT
gives rise to the bed nucleus of the stria medullaris and that
of the posterior part of the stria terminalis (Puelles et al.
2000). Although our current study cannot provide any
information on the fate of the EmT, adapting our experi-
mental protocol using homotopic explants from tau-GFP
mouse donors could generate valuable data regarding the
fate of EmT cells.
cFig. 7 Ascl1, Lef1 and Pax6 expression in the ventral telencephalon
of cultured slices. a A schematic representation of Ascl1 (green dots)
and Lef1 (red dots) expression observed in slices with EmT explants.
In sections with explants present, Ascl1 was not seen within the
explants (depicted with a black outline) but was found in ventral
telencephalic cells surrounding them. In slices hosting two EmT
explants, Lef1-positive cells mingled with Ascl1-positive cells within
the ventral telencephalon and outside the explant region. b–b3 Serial
cryostat sections of a slice culture with two tau-GFP EmT explants on
the left hemisphere. GFP immunofluorescence shows explant position
in b. Sections (b1–b3) are serial sections located in deeper layers to
b. In these sections, the GFP staining is gradually reduced (b1, b2) and
eventually disappears (b3). c A section with an EmT explant present
(outlined in white). Ascl1 staining is seen in the ventricular zone and
mantle layer around the explant but not in the explant per se. d, d1
Ascl1 and Lef1 expression in the experimental half of a slice hosting
two EmT explants. Both Ascl1-positive (green) and Lef1-positive
(red) cells are seen in the ventricular zone and mantle layer of the
ventral telencephalon. The dotted square in d outlines the high power
image in d1. d is a section adjacent to b3. As with b3, the explant is not
visible anymore in d. However, its position corresponds to that of the
dotted squares in panels b–b3. At higher magnifications (e1–e4), many
single-labelled Lef1-positive cells (arrows in e3) are found mingling
with single-labelled Ascl1-expressing cells (arrows in e2). Blue
staining (b–b3; e1–e4) is DAPI counterstain. f1–f4 Lef1 and Pax6
expression in the experimental half of a host slice. The blue staining
in f1 corresponds to the tau-GFP EmT explant. Dorsal to the explant, a
group of Lef1-positive cells are found (red in f2). Most of these cells
seem to co-express the dorsal telencephalic marker Pax6 (green in f3,
f4). The dotted square in f1 corresponds to the high magnifications in
f2–f3. The arrows in f3 point to Pax6-positive cells within the GFP-
positive EmT. Abbreviations: dmt dorsomedial telencephalon; EmT
eminentia thalami; nctx neocortex; PTh prethalamus, Th thalamus,
Vtel ventral telencephalon. Scale bars b–b3, f1 = 200 lm; c,
d = 100 lm; d1, f2–f4 = 50 lm; e1–e4 = 25 lm
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Conclusions
The EmT is a Wnt-rich expressing region with an ability
to induce the fate of surrounding cells away from its
original source. These properties strongly support its role
as a forebrain signalling centre. Future experiments will
explore further this potential and will also examine the
properties of the other signalling molecules expressed in
the EmT.
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